TrialCancer chemotherapy and pharmacology2011

A prospective phase II study of 2-methoxyestradiol administered in combination with bevacizumab in patients with metastatic carcinoid tumors.

Matthew H Kulke et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.